ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for SPYRE THERAPEUTICS, INC. · Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.

Filing Registration

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · posted Nov 17, 2025

Lobbying activity 3

Medical/Disease Research/Clinical Labs

FDA policies relating to monoclonal antibody products.

Pharmacy

FDA policies relating to monoclonal antibody products.

Health Issues

FDA policies relating to monoclonal antibody products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.